Skip to main content
    T

    Tenet Healthcare Corporation (THC)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NYSE

    $291.90
    +5.88 (+2.05%)

    Market Cap: $22.76B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Tenet Healthcare Corporation (THC) Earnings: Report Dates and Results

    Updated Oct 29, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Tenet Healthcare (THC) is expected to report earnings on Feb 9, 2027. In the quarter ended Sep 30, 2026, Tenet Healthcare reported EPS of $6.64, above the $4.60 estimate. It beat the EPS estimate in each of the last 34 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    97%(38/39)
    Avg Surprise
    +64.31%
    Streak
    38 Q

    Upcoming Estimates

    Reports Feb 9, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus$5.34
    Range$4.38 - $6.39
    22 analysts
    Revenue Consensus
    $5.72B
    Range$5.49B - $6.08B
    20 analysts
    Reports Apr 28, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus$4.53
    Range$3.85 - $5.34
    12 analysts
    EPS Revisions
    0
    5
    30d
    EPS Estimate DriftChange to current
    90d ago$4.83-6.2%
    60d ago$4.91-7.8%
    30d ago$4.93-8.1%
    7d ago$4.59-1.2%
    Current$4.53
    Revenue Consensus
    $5.46B
    Range$5.29B - $5.65B
    8 analysts

    Next Report

    THC has an expected report date of Feb 9, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 13.6% above the $4.70 reported for the quarter ended Dec 31, 2025.

    THC Earnings Call

    The latest THC earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 39 quarters below that had an estimate, THC beat 38 and missed 1. Revenue for the quarter ended Sep 30, 2026 was $5.63B, up 6.4% from $5.29B a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026$6.64$4.60$4.03 - $5.11+44.35%Beat+79.5%201 up, 1 downOct 29, 2026$5.63B
    Jun 30, 2026$6.12$4.08$3.58 - $5.17+50.00%Beat+52.2%181 up, 0 downJul 22, 2026$5.63B
    Mar 31, 2026$4.82$4.17$3.08 - $4.66+15.59%Beat+10.6%181 up, 9 downApr 30, 2026$5.37B
    Dec 31, 2025$4.70$4.07$3.66 - $4.29+15.48%Beat+36.6%194 up, 1 downFeb 11, 2026$5.53B
    Sep 30, 2025$3.70$3.35$3.12 - $3.76+10.45%Beat+26.3%192 up, 0 downOct 28, 2025$5.29B
    Jun 30, 2025$4.02$2.87$2.51 - $3.15+40.07%Beat+74.0%185 up, 0 downJul 22, 2025$5.27B
    Mar 31, 2025$4.36$3.13$2.85 - $3.44+39.30%Beat+35.4%191 up, 2 downApr 29, 2025$5.22B
    Dec 31, 2024$3.44$2.83$1.48 - $3.08+21.45%Beat+28.4%164 up, 1 downFeb 12, 2025$5.07B
    Sep 30, 2024$2.93$2.37$1.67 - $2.64+23.63%Beat+103.5%1615 up, 0 downOct 29, 2024$5.13B
    Jun 30, 2024$2.31$1.91$1.61 - $2.52+20.94%Beat+60.4%174 up, 0 downJul 24, 2024$5.11B
    Mar 31, 2024$3.22$1.44$1.04 - $1.56+123.61%Beat+126.8%161 up, 0 downApr 30, 2024$5.37B
    Dec 31, 2023$2.68$1.62N/A+65.43%Beat+36.7%N/AN/AFeb 8, 2024$5.38B
    Sep 30, 2023$1.44$1.20N/A+20.00%Beat0.0%N/AN/AOct 30, 2023$5.07B
    Jun 30, 2023$1.44$1.25$0.94 - $1.53+15.20%Beat-4.0%155 up, 0 downJul 31, 2023$5.09B
    Mar 31, 2023$1.42$1.15$0.95 - $1.33+23.48%Beat-26.4%154 up, 1 downApr 25, 2023$5.02B
    Dec 31, 2022$1.96$1.23$0.74 - $1.49+59.35%Beat-27.4%141 up, 0 downFeb 9, 2023$5.03B
    Sep 30, 2022$1.44$1.22$0.96 - $1.36+18.03%Beat-27.6%151 up, 0 downOct 20, 2022$4.86B
    Jun 30, 2022$1.50$0.80$0.35 - $1.60+87.50%Beat-5.7%140 up, 2 downJul 21, 2022$4.73B
    Mar 31, 2022$1.93$1.06$0.90 - $1.34+82.08%Beat+48.5%150 up, 1 downApr 20, 2022$4.75B
    Dec 31, 2021$2.70$1.49$1.18 - $2.13+81.21%Beat-42.8%153 up, 0 downFeb 7, 2022N/A
    Sep 30, 2021$1.99$1.08$0.73 - $1.69+84.26%Beat+210.9%15N/AOct 20, 2021$4.89B
    Jun 30, 2021$1.59$1.07$0.93 - $1.27+48.60%Beat+26.2%12N/AJul 21, 2021$4.97B
    Mar 31, 2021$1.30$0.72$0.34 - $1.10+80.56%Beat+1.6%13N/AApr 20, 2021$4.81B
    Dec 31, 2020$4.72$1.81$0.47 - $4.05+160.77%Beat+376.8%15N/AFeb 9, 2021$9.00B
    Sep 30, 2020$0.64$0.24-$0.23 - $1.33+166.67%Beat+10.3%16N/AOct 20, 2020$4.49B
    Jun 30, 2020$1.26-$0.71-$2.17 - $0.67+277.46%Beat+125.0%16N/AAug 3, 2020$511.00M
    Mar 31, 2020$1.28$0.37-$0.41 - $0.66+245.95%Beat+137.0%17N/AMay 4, 2020$4.52B
    Dec 31, 2019$0.99$0.98$0.80 - $1.17+1.02%Beat+94.1%17N/AFeb 24, 2020$4.81B
    Sep 30, 2019$0.58$0.32$0.02 - $0.56+81.25%Beat+100.0%18N/ANov 4, 2019$4.57B
    Jun 30, 2019$0.56$0.44$0.36 - $0.57+27.27%Beat+14.3%19N/AAug 5, 2019$4.56B
    Mar 31, 2019$0.54$0.29$0.15 - $0.42+86.21%Beat-5.3%20N/AApr 29, 2019$4.54B
    Dec 31, 2018$0.51$0.28$0.11 - $0.54+82.14%Beat-63.6%21N/AFeb 25, 2019$4.62B
    Sep 30, 2018$0.29$0.12$0.04 - $0.24+141.67%BeatN/A17N/ANov 5, 2018$4.49B
    Jun 30, 2018$0.49$0.23$0.15 - $0.47+113.04%BeatN/A16N/AAug 6, 2018$4.51B
    Mar 31, 2018$0.57-$0.04-$0.53 - $0.04N/AN/AN/A12N/AApr 30, 2018$4.70B
    Dec 31, 2017$1.40$1.24$1.05 - $1.36+12.90%Beat+2233.3%16N/AFeb 26, 2018$5.30B
    Sep 30, 2017-$0.17-$0.43-$0.60 - -$0.24+60.47%Beat-206.3%13N/AOct 27, 2017$4.94B
    Jun 30, 2017-$0.17-$0.18-$0.38 - $0.05+5.56%Beat-144.7%18N/AAug 7, 2017$5.17B
    Mar 31, 2017-$0.27-$0.52N/A+48.08%Beat-160.0%N/AN/AMay 1, 2017$5.20B
    Dec 31, 2016$0.06$0.22N/A-72.73%Miss-82.9%N/AN/AFeb 27, 2017$5.21B
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was $16.78, up 41.0% from the year before. It was $1.05 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025$16.78+41.0%
    Dec 31, 2024$11.90+70.5%
    Dec 31, 2023$6.98+2.2%
    Dec 31, 2022$6.83-9.9%
    Dec 31, 2021$7.58-4.1%
    Dec 31, 2020$7.90+195.9%
    Dec 31, 2019$2.67+43.5%
    Dec 31, 2018$1.86+135.4%
    Dec 31, 2017$0.79-24.8%
    Dec 31, 2016$1.05N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 7,200 words across 19 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20267,19719
    2026Q2Jun 30, 20267,59317
    2026Q1Mar 31, 20265,19217
    2025Q4Dec 31, 20257,24620
    2025Q3Sep 30, 20255,43617
    2025Q2Jun 30, 20256,75818
    2025Q1Mar 31, 20257,09018
    2024Q4Dec 31, 20246,83020

    2026Q3 Earnings Call

    Opening remarks

    William McDowell Vice President of Investor Relations Good morning, everyone, and thank you for joining today's call. I am Will McDowell, Vice President of Investor Relations. We are pleased to have you join us for a discussion of Tenet's third quarter 2026 results, as well as a discussion of our financial outlook. Tenet senior management participating in today's call will be Dr. Saumya Sutaria, Chairman and Chief Executive Officer, and Sun K. Park, Executive Vice President and Chief Financial Officer. The webcast this morning includes a slide presentation, which has been posted to the Investor Relations section of our website, tenethealth.com. Listeners to this call are advised that certain statements made during our discussion today are forward-looking and represent management's expectations based on currently available information. Actual results and plans could differ materially. Tenet is under no obligation to update any forward-looking statements based on subsequent information. Investors should take note of the cautionary statement slide included in today's presentation, as well as the risk factors discussed in our most recent Form 10-Ks and other filings with the Securities and Exchange Commission. With that, I will turn the call over to Saumya.

    Saumya Sutaria Chairman and Chief Executive Officer Thank you, Will, and good morning, everyone. Third quarter net operating revenues were $5.6 billion, and consolidated adjusted EBITDA was $1.355 billion. Adjusted diluted earnings per share increased 80% to $6.40 in the third quarter of 2026 compared to the prior year. More importantly, after adjusting for one-time items related to contract transitions that generated adjusted EBITDA of $147 million that was not reflected in our previous guidance, the core business continued its strong growth trajectory in 2026, with an adjusted EBITDA margin of 21.8% and growth in adjusted EBITDA over the third quarter of 2025. We continue to manage through payer mix shifts and enrollment declines in the exchanges, and execute on our technology-enabled growth and expense management plans that support our margin strength. Our strong performance is driving significant free cash flow that we continue to deploy for the benefit of shareholders. Year to date, we have deployed over $1.6 billion for share repurchases. Now turning to our segments, USPI generated $537 million in adjusted EBITDA, which represents 9% growth over the third quarter of 2025. Same-facility revenues grew 4.5%, as our high-acuity strategy continues to yield benefits and is highlighted by our strongest quarterly performance this year, with 12.8% same-store growth in total joint replacements in the ASCs over the prior year. USPI also had a very successful quarter in development, with over $100 million of investments in the third quarter alone. We remain the preferred acquirer of assets in this space and continue to have an attractive pipeline of partnerships interested in joining USPI.

    Frequently Asked Questions About THC

    When is Tenet Healthcare's next earnings date?

    Tenet Healthcare's next earnings report is expected for Feb 9, 2027.

    Did THC beat earnings estimates last quarter?

    Yes. Tenet Healthcare reported EPS of $6.64 for the quarter ended Sep 30, 2026, above the $4.60 estimate, a 44.35% surprise.

    What EPS do analysts expect from THC next quarter?

    The consensus EPS estimate for Tenet Healthcare for the quarter ending Dec 31, 2026 is $5.34 from 22 analysts, with estimates from $4.38 to $6.39.

    How often does THC beat earnings estimates?

    Tenet Healthcare beat the EPS estimate in each of the last 34 quarters, with an average surprise of +72.18%.